Ligand validation:5RCC

RDV: 3-cyclopentyl-1-(piperazin-1-yl)propan-1-one

RDV is a Ligand Of Interest in 5RCC designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5RCC_RDV_A_402	28%	61%	0.186	0.837	0.43	1.05	-	1	0	0	100%	0.27
5RCC_RDV_A_401	5%	59%	0.293	0.713	0.44	1.13	-	1	2	0	100%	0.27
5R2A_RDV_A_402	6%	75%	0.332	0.776	0.34	0.63	-	-	1	0	100%	0.48
8CFU_RDV_A_503	12%	17%	0.227	0.758	2.41	1.24	5	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.